Clinical application and advance of regadenoson stress myocardial perfusion imaging
Dongzhu Yang, Lei Wang
Abstract
Dongzhu Yang, Lei Wang
Abstract
Vasodilator stress MPI plays an important role in the detection of abnormal myocardial perfusion. Currently as the only selective A2A adenosine receptor agonist approved by FDA, the new myocardial stress agent regadenoson has been increasingly used in vasodilator stress MPI on clinic. This review describes the pharmacologic properties and overviews the clinical data on regadenoson, especially its diagnostic efficacy, prognosis predicting value and adverse effect as a vasodilator stress agent. Key words: Myocardial perfusion imaging; Adenosine A2 receptor agonists; Trends
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Vasodilator stress MPI plays an important role in the detection of abnormal myocardial perfusion. Currently as the only selective A2A adenosine receptor agonist approved by FDA, the new myocardial stress agent regadenoson has been increasingly used in vasodilator stress MPI on clinic. This review describes the pharmacologic properties and overviews the clinical data on regadenoson, especially its diagnostic efficacy, prognosis predicting value and adverse effect as a vasodilator stress agent. Key words: Myocardial perfusion imaging; Adenosine A2 receptor agonists; Trends
Key concepts: Regadenoson, Myocardial perfusion imaging, Medicine, Vasodilation, Perfusion, Adenosine, Cardiology, Coronary vasodilator